In this Issue:
Opt-in, active choice or opt-out HIV testing?
Pre-exposure prophylaxis for HIV infection
NRTIs in HIV salvage therapy
Treatment intensification plus IL-7
Frailty in middle-aged HIV-1 patients
Long-term mortality in the over 50s with HIV
Duration of ART interruption and virologic rebound
Time from HIV diagnosis to viral load suppression
Topical cidofovir for high-grade anal intraepithelial neoplasia
Switching tenofovir disoproxil fumarate to tenofovir alafenamide
Please login below to download this issue (PDF)